Rathnam Pharmaceuticals Private Limited, a active private limited company, was established on 30 May 2012 in Tirupati, Andhra Pradesh, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24233AP2012PTC081199. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹7.50 Cr and a paid-up capital of ₹5.73 Cr.
It upholds a active non-compliant status. Its leadership includes Danamjaya Chinnabba (Managing Director), Munirathnam Madithotta (Director). Past directors included Satish Kumar Burra, Danamjaya Chinnabba, Pandu Kuna. It holds ₹8.18 Cr open charges and no settled loans. Its latest AGM occurred on 13 September 2018, with the balance sheet filed on 31 March 2018. It is based at D.No.6-137 Dhanalakshmi Nagar Avilala, Tirupati, Andhra Pradesh, 517502.
U24233AP2012PTC081199
081199
30 May 2012
₹7.50 Cr
₹5.73 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Rathnam Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Danamjaya Chinnabba | Managing Director | 10 Jun 2013 | Current |
| Munirathnam Madithotta | Director | 30 May 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Dec 2017 | Past |
| Pramod Abcsdd | Director | 12 Feb 2016 | Past |
| Pramod Abcsdd | Director | 14 Jul 2014 | Past |
| Pramod Abcsdd | Director | 14 Mar 2014 | Past |
| Pramod Abcsdd | Director | 22 Apr 2019 | Past |
| Pramod Abcsdd | Director | 14 Dec 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rathnam Pharmaceuticals Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 52368.83% increase. The company also saw a substantial improvement in profitability, with a 53869.57% increase in profit. The company's net worth moved up by a moderate rise of 3.58%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Rathnam Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹81,800,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2017 | Syndicate Bank | ₹4.00 Cr | Open |
| 28 Jan 2016 | Ifci Venture Capital Funds Limited | ₹4.18 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Rathnam Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rathnam Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rathnam Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Rathnam Pharmaceuticals Private Limited last Annual general meeting of members was held on 13 Sep 2018 as per latest MCA records. was completed.
Rathnam Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Vijayawada. was recorded as a recent event.
A charge with Syndicate Bank amounted to Rs. 4.00 Cr with Charge ID 100090820 was registered on 30 Mar 2017. was recorded as a recent event.
The activity A charge with Ifci Venture Capital Funds Limited amounted to Rs. 4.18 Cr with Charge ID 10617240 was registered on 28 Jan 2016. was completed.
The activity Danamjaya Chinnabba was appointed as a Managing Director was appointed as a Managing Director on 10 Jun 2013 & has been associated with this company since 12 years 5 months . was completed.
Progress on Munirathnam Madithotta was appointed as a Director was appointed as a Director on 30 May 2012 & has been associated with this company since 13 years 6 months . was documented.
The CIN of Rathnam Pharmaceuticals Private Limited is U24233AP2012PTC081199.
Rathnam Pharmaceuticals Private Limited is headquartered at D.No.6-137 Dhanalakshmi Nagar Avilala, Tirupati, Andhra Pradesh, 517502.
Rathnam Pharmaceuticals Private Limited was incorporated on 30 May 2012.
The current directors of Rathnam Pharmaceuticals Private Limited are
The primary industry of Rathnam Pharmaceuticals Private Limited is Pharma.
Rathnam Pharmaceuticals Private Limited is unlisted.
The authorized capital of Rathnam Pharmaceuticals Private Limited is ₹7.50 Cr, and the paid-up capital is ₹5.73 Cr.
The compliance status of Rathnam Pharmaceuticals Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX